Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00192608
Status:
COMPLETED
Last Update Posted:
2009-06-26
First Post:
2005-09-13
Brief Title:
A 48-Week Randomised Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation the ASK-500 Study
Sponsor:
Kirby Institute
Organization:
Kirby Institute
Organization Data
Organization:
Kirby Institute
Class:
OTHER_GOV
Study ID:
ASK-500 14047
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kirby Institute
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
The University of New South Wales
Old Organization:
University
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |